2918
X. Yang, A. K. Yudin
LETTER
(11) In a flame-dried Schlenk flask, equipped with septum,
magnetic stir bar, and nitrogen inlet, were placed NIS (1.2
equiv), powdered 4 Å MS (180 mg/mol aziridine), anhyd
CH2Cl2 (0.11 mmol/mL) under nitrogen atmosphere at 0 °C.
Aziridine-2-carboxylate methyl ester (1.0 equiv) was added
via syringe. After 30 min, when TLC showed no aziridine
remaining, galvinoxyl (1.0 equiv) was added, followed by
the addition of styrene. The reaction mixture was allowed to
warm up to r.t. and stirred for 8 h. A control experiment was
set up at the same time to compare the effect of the radical
trap. After 8 h, the control experiment in the absence of
galvinoxyl proceeded smoothly and the anti-Markovnikov
product was afforded, while no desired product was formed
in the presence of galvinoxyl.
(13) (a) Audier, L.; Azzaro, M.; Cambon, A.; Guedj, R. Bull. Soc.
Chim. Fr. 1968, 1013. (b) Audier, L.; Azzaro, M.; Cambon,
A.; Guedj, R. Bull. Soc. Chim. Fr. 1968, 1021.
(14) Martinez, A.; Elguero, J.; Mo, O.; Yanez, M. J. Mol. Struct.
(Theochem) 1994, 309, 45.
(15) Lee, K.-D.; Suh, J.-M.; Park, J.-H.; Ha, H.-J.; Choi, H. G.;
Park, S. P.; Chang, J. W.; Lee, W. K.; Dong, Y.; Yun, H.
Tetrahedron 2001, 57, 8267.
(16) Park, C. S.; Kim, M. S.; Sim, T. B.; Pyun, D. K.; Lee, C. H.;
Choi, D.; Lee, W. K. J. Org. Chem. 2003, 68, 43.
(17) Sim, T. B.; Kang, S. H.; Lee, K. S.; Lee, W. K. J. Org. Chem.
2003, 68, 104.
(18) Fink, D. M.; Smith, H. K. Aventis Pharma Inc. (USA)
WO2006086705, 2006.
(12) Typical Procedure for the Nucleophilic Substitution of
b-Haloaziridines with Amines
(19) Procedure for the Synthesis of 30
In a 5 mL Schlenk tube, equipped with septum and magnetic
stir bar, were placed 19 (0.1 mmol), K2CO3 (0.22 mmol), and
anhyd MeCN (1 mL). Oxalyl chloride was added via syringe
and the solution was stirred at 60 °C for 2 h. When TLC
showed no starting material remaining, the solution was
filtered and the filtrated was washed with H2O. The organic
layer was dried over anhyd Na2SO4 and filtered. The filtrated
was concentrated in vacuo and the light brown residue was
directly used in the next step without purification.
Reduction with LiAlH4
To a mixture of 4 (50 mg, 0.122 mmol) and DMF (2.5 mL)
was added allylamine (91.5 mL, 12.2 mmol) at r.t. and the
mixture stirred for 12 h. When TLC showed no 4 remaining,
H2O (4 mL) and Et2O (2 mL) were added, the layers were
then separated. The ether layer was washed with H2O
followed by drying over Na2SO4. The solvent was removed
in vacuo and the oily residue was subjected to
chromatography on alumina, eluted with hexane–EtOAc
(80:20), to give the product 15 as light yellow oil.
Methyl 1-[2-Allylamino-2-(2-bromophen-yl)ethyl]azir-
idine-2-carboxylate (15)
To a suspension of 300 mg LiAlH4 (7.91 mmol) in 40 mL
THF, 264 mg crude product of diketopiperazine 29 (0.66
mmol) dissolved in 5 mL THF was added. The mixture was
stirred at 60 °C for 12 h. After cooling to 0 °C, H2O (0.4 mL),
15% NaOH (0.4 mL), and H2O (0.4 mL) were added
dropwise while stirring. The mixture was filtered and the
filtrate was concentrated in vacuo. The residue was
subjected to silica gel chromatography, eluted with CH2Cl2–
MeOH (90:10). Yield 40%.
Yield 75%. 1H NMR (400 MHz, CDCl3): d = 7.63–7.62 (m,
1 H), 7.52–7.49 (m, 1 H), 7.32–7.28 (m, 1 H), 7.13–7.09 (m,
1 H), 5.92–5.84 (m, 1 H), 5.19–5.06 (m, 2 H), 4.34–4.31 (m,
1 H), 3.71 (s, 3 H), 3.12–3.07 (m, 2 H), 2.76–2.71 (m, 2 H),
2.22–2.16 (m, 1 H), 2.03–2.00 (m, 1 H), 1.73–1.71 (m, 1 H).
13C NMR (100 MHz, CDCl3): d = 171.36, 140.20, 136.91,
133.02, 129.02, 127.91, 127.89, 124.12, 116.00, 65.72,
60.72, 52.37, 50.11, 38.13, 34.16.
Reduction with BH3·SMe2
Typical Procedure for the Nucleophilic Substitution of
b-Haloamines with Alcohols Facilitated by Silver Salts
To a mixture of 4 (100 mg, 0.302 mmol), allyl alcohol (205
mL, 0.302 mmol), K2CO3 (50.0 mg, 0.362 mmol), and anhyd
CH2Cl2 (10 mL), was added AgOTf (77.6 mg, 0.302 mmol)
at r.t. and the mixture was stirred for 30 min. When TLC
showed no 4 remaining, the mixture was filtered and
concentrated in vacuo. The oily residue was subjected to
chromatography on silica gel, eluted with hexane–EtOAc
(70:30), to give the product 23 as light yellow oil.
To a solution of crude product of diketopiperazine 29 in
anhyd THF (10 mL/mmol) under reflux was added dropwise
9 equiv of a 2 M solution of BH3·SMe2 in THF. The mixture
was refluxed for 7 h, the solvent was evaporated under
reduced pressure, and 4 equiv of a 0.2–0.4 M HCl solution
were added. The mixture was stirred for 30 min at 100 °C,
and then it was cooled to 0 °C, and 6 equiv of a 0.2–0.4 M
solution of NaOH were added. Then, the mixture was stirred
for a further 90 min. The aqueous mixture was saturated with
solid K2CO3 and extracted with CH2Cl2 (3–4 times, 5 mL/
mmol), and the combined organic extracts were dried over
Na2SO4, filtered, and concentrated in vacuo. The residue was
subjected to silica gel chromatography, eluted with CH2Cl2–
MeOH (90:10). Yield 20%.
3-(4-Benzyl-3-phenylpiperazin-1-yl)propan-1-ol (30)
Yield 40%. 1H NMR (400 MHz, CDCl3): d = 7.50–7.19 (m,
10 H), 3.82–3.77 (m, 3 H), 3.03–2.78 (m, 4 H), 2.64–2.57
(m, 2 H), 2.42–2.11 (m, 2 H), 0.89–0.87 (m, 2 H). 13C NMR
(100 MHz, CDCl3): d = 141.9, 139.1, 129.0, 128.9, 128.8,
128.4, 128.2, 127.9, 127.0, 67.6, 64.9, 62.3, 59.1, 53.6, 51.9,
27.2, 9.7.
Methyl 1-[2-(Allyloxy)-2-(2-bromophenyl)ethyl]azir-
idine-2-carboxylate (23)
Yield 36%. 1H NMR (400 MHz, CDCl3): d = 7.53–7.47 (m,
4 H), 7.45–7.32 (m, 2 H), 7.16–7.12 (m, 2 H), 5.92–5.86 (m,
2 H), 5.30–5.24 (m, 2 H), 5.18–5.15 (d, J = 10.4 Hz, 2 H),
3.99–3.83 (m, 4 H), 3.72 (s, 6 H), 3.00–2.98 (m, 1 H), 2.69–
2.67 (m, 1 H), 2.50–2.45 (m, 1 H), 2.27–2.26 (m, 2 H), 2.15–
2.13 (m, 1 H), 2.13–2.08 (m, 1 H), 2.08–2.04 (m, 1 H), 1.80–
1.78 (d, J = 6.8 Hz, 1 H), 1.59–1.57 (d, J = 6.4 Hz, 1 H). 13
NMR (100 MHz, CDCl3): d = 171.5, 139.4, 134.8, 134.7,
133.0, 129.5, 129.4, 128.3, 128.3, 127.9, 123.1, 123.1,
C
117.1, 117.0, (79.9, 79.62), (70.5, 70.3), (65.3, 65.2), (52.3,
52.2), (39.1, 36.7), (35.4, 32.8).
Synlett 2007, No. 18, 2912–2918 © Thieme Stuttgart · New York